Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bronchoscopy | 28 | 2024 | 909 | 4.990 |
Why?
|
Pleural Diseases | 6 | 2022 | 137 | 2.300 |
Why?
|
Pleural Effusion | 8 | 2022 | 341 | 2.230 |
Why?
|
Lung Diseases, Interstitial | 9 | 2023 | 918 | 2.150 |
Why?
|
Idiopathic Pulmonary Fibrosis | 8 | 2023 | 514 | 1.820 |
Why?
|
Pleural Effusion, Malignant | 4 | 2019 | 106 | 1.640 |
Why?
|
Pleura | 4 | 2020 | 244 | 1.590 |
Why?
|
Solitary Pulmonary Nodule | 3 | 2024 | 279 | 1.410 |
Why?
|
Pulmonary Emphysema | 6 | 2024 | 683 | 1.410 |
Why?
|
Tracheobronchomalacia | 5 | 2020 | 131 | 1.370 |
Why?
|
Pleurisy | 2 | 2020 | 54 | 1.360 |
Why?
|
Thoracoscopy | 6 | 2020 | 183 | 1.290 |
Why?
|
Airway Obstruction | 4 | 2024 | 660 | 1.180 |
Why?
|
Catheters | 3 | 2019 | 426 | 1.050 |
Why?
|
Pneumonectomy | 6 | 2024 | 1118 | 1.010 |
Why?
|
Jugular Veins | 2 | 2017 | 210 | 1.010 |
Why?
|
Lung Neoplasms | 14 | 2024 | 13382 | 0.950 |
Why?
|
Empyema, Pleural | 3 | 2022 | 61 | 0.920 |
Why?
|
Lung | 12 | 2023 | 9979 | 0.900 |
Why?
|
Drainage | 8 | 2020 | 1158 | 0.880 |
Why?
|
Cough | 5 | 2024 | 594 | 0.870 |
Why?
|
Ultrasonography, Interventional | 3 | 2017 | 1496 | 0.850 |
Why?
|
Pneumothorax | 3 | 2023 | 386 | 0.840 |
Why?
|
Biopsy | 7 | 2022 | 6781 | 0.810 |
Why?
|
Prostheses and Implants | 5 | 2023 | 1276 | 0.810 |
Why?
|
Argon Plasma Coagulation | 2 | 2021 | 25 | 0.810 |
Why?
|
Deoxyribonucleases | 3 | 2018 | 209 | 0.800 |
Why?
|
Catheterization, Central Venous | 2 | 2017 | 526 | 0.770 |
Why?
|
Tissue Plasminogen Activator | 5 | 2022 | 1162 | 0.730 |
Why?
|
Trachea | 3 | 2021 | 1090 | 0.650 |
Why?
|
Thoracostomy | 1 | 2019 | 74 | 0.630 |
Why?
|
Tracheal Stenosis | 2 | 2017 | 228 | 0.610 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2021 | 173 | 0.610 |
Why?
|
Chest Tubes | 6 | 2020 | 152 | 0.590 |
Why?
|
Physical Exertion | 1 | 2020 | 668 | 0.590 |
Why?
|
Cone-Beam Computed Tomography | 2 | 2023 | 474 | 0.580 |
Why?
|
Endosonography | 3 | 2023 | 608 | 0.570 |
Why?
|
Catheters, Indwelling | 1 | 2019 | 426 | 0.570 |
Why?
|
Fibrinolytic Agents | 5 | 2022 | 2075 | 0.560 |
Why?
|
Tracheostomy | 1 | 2020 | 426 | 0.540 |
Why?
|
Fluid Therapy | 1 | 2020 | 578 | 0.530 |
Why?
|
Dyspnea | 3 | 2020 | 1347 | 0.510 |
Why?
|
Intensive Care Units | 4 | 2019 | 3743 | 0.500 |
Why?
|
Phenytoin | 1 | 2016 | 190 | 0.490 |
Why?
|
Catheterization | 2 | 2019 | 1428 | 0.490 |
Why?
|
Cryopreservation | 1 | 2020 | 728 | 0.480 |
Why?
|
Thrombolytic Therapy | 2 | 2020 | 2055 | 0.470 |
Why?
|
Learning Curve | 1 | 2016 | 230 | 0.470 |
Why?
|
Cryosurgery | 1 | 2019 | 474 | 0.460 |
Why?
|
Chest Pain | 2 | 2020 | 1095 | 0.460 |
Why?
|
Infection Control | 2 | 2020 | 983 | 0.460 |
Why?
|
Thoracic Surgery, Video-Assisted | 4 | 2022 | 285 | 0.450 |
Why?
|
Catheterization, Peripheral | 1 | 2017 | 343 | 0.450 |
Why?
|
Pulmonary Medicine | 3 | 2023 | 221 | 0.440 |
Why?
|
Granuloma | 1 | 2016 | 327 | 0.440 |
Why?
|
Thoracic Surgical Procedures | 4 | 2022 | 350 | 0.410 |
Why?
|
Ventilator Weaning | 1 | 2013 | 164 | 0.400 |
Why?
|
Respiratory Rate | 1 | 2013 | 176 | 0.400 |
Why?
|
Osteitis Fibrosa Cystica | 1 | 2011 | 11 | 0.400 |
Why?
|
Actinomycosis | 1 | 2011 | 19 | 0.390 |
Why?
|
Actinomyces | 1 | 2011 | 40 | 0.390 |
Why?
|
Vasculitis | 1 | 2016 | 522 | 0.380 |
Why?
|
Critical Illness | 2 | 2015 | 2709 | 0.370 |
Why?
|
Mediastinal Neoplasms | 2 | 2019 | 401 | 0.370 |
Why?
|
Humans | 84 | 2024 | 761098 | 0.360 |
Why?
|
Biopsy, Needle | 2 | 2012 | 1624 | 0.360 |
Why?
|
Surgical Stapling | 2 | 2022 | 98 | 0.350 |
Why?
|
Hyperparathyroidism | 1 | 2011 | 337 | 0.350 |
Why?
|
Parathyroid Neoplasms | 1 | 2011 | 242 | 0.350 |
Why?
|
Ultrasonography | 4 | 2020 | 5971 | 0.350 |
Why?
|
Physical Examination | 1 | 2015 | 1255 | 0.330 |
Why?
|
Length of Stay | 4 | 2020 | 6420 | 0.330 |
Why?
|
Genomics | 3 | 2023 | 5828 | 0.310 |
Why?
|
Educational Measurement | 1 | 2015 | 1251 | 0.310 |
Why?
|
Respiratory Function Tests | 5 | 2019 | 1685 | 0.310 |
Why?
|
Pulmonary Fibrosis | 2 | 2022 | 505 | 0.300 |
Why?
|
Forced Expiratory Volume | 3 | 2024 | 1813 | 0.290 |
Why?
|
Kidney Calculi | 1 | 2011 | 463 | 0.280 |
Why?
|
Respiration, Artificial | 2 | 2019 | 2630 | 0.280 |
Why?
|
Bronchi | 2 | 2021 | 843 | 0.270 |
Why?
|
Education, Medical, Undergraduate | 1 | 2015 | 1071 | 0.270 |
Why?
|
Quality of Life | 7 | 2024 | 13362 | 0.270 |
Why?
|
Tomography, X-Ray Computed | 15 | 2024 | 20600 | 0.270 |
Why?
|
Pleurodesis | 2 | 2016 | 46 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3094 | 0.260 |
Why?
|
Stents | 3 | 2024 | 3177 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3216 | 0.260 |
Why?
|
Male | 40 | 2024 | 360675 | 0.260 |
Why?
|
Anticonvulsants | 1 | 2016 | 1911 | 0.260 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2757 | 0.260 |
Why?
|
Lung Diseases | 1 | 2016 | 1909 | 0.250 |
Why?
|
Anemia | 2 | 2015 | 1504 | 0.250 |
Why?
|
Pneumonia | 2 | 2019 | 2142 | 0.240 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2015 | 3200 | 0.230 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 2024 | 94 | 0.230 |
Why?
|
Glucose | 1 | 2016 | 4341 | 0.230 |
Why?
|
Clinical Competence | 3 | 2016 | 4786 | 0.230 |
Why?
|
Aged | 25 | 2024 | 169266 | 0.230 |
Why?
|
Retrospective Studies | 21 | 2023 | 80673 | 0.230 |
Why?
|
Middle Aged | 30 | 2024 | 220835 | 0.230 |
Why?
|
Airway Management | 2 | 2018 | 312 | 0.220 |
Why?
|
Feasibility Studies | 6 | 2020 | 5249 | 0.220 |
Why?
|
Tuberculosis, Pulmonary | 2 | 2020 | 830 | 0.220 |
Why?
|
Gastroesophageal Reflux | 2 | 2022 | 821 | 0.210 |
Why?
|
Lymph Nodes | 2 | 2018 | 3461 | 0.200 |
Why?
|
Argon | 1 | 2021 | 36 | 0.190 |
Why?
|
Tuberculosis, Multidrug-Resistant | 2 | 2020 | 934 | 0.190 |
Why?
|
Sheep | 2 | 2021 | 1436 | 0.190 |
Why?
|
Antitubercular Agents | 2 | 2020 | 1375 | 0.190 |
Why?
|
Xanthomatosis | 1 | 2020 | 32 | 0.180 |
Why?
|
Vital Capacity | 3 | 2023 | 970 | 0.180 |
Why?
|
Prosthesis Implantation | 3 | 2020 | 591 | 0.180 |
Why?
|
Female | 31 | 2024 | 392458 | 0.180 |
Why?
|
Diagnosis, Differential | 6 | 2020 | 12975 | 0.180 |
Why?
|
Hemothorax | 1 | 2020 | 58 | 0.180 |
Why?
|
Surgical Instruments | 2 | 2019 | 383 | 0.170 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 2019 | 45 | 0.170 |
Why?
|
Infusion Pumps | 1 | 2020 | 163 | 0.170 |
Why?
|
Fusobacterium Infections | 1 | 2019 | 53 | 0.160 |
Why?
|
Asthma | 1 | 2017 | 6229 | 0.160 |
Why?
|
Respiratory Tract Fistula | 1 | 2018 | 25 | 0.160 |
Why?
|
Mediastinum | 2 | 2018 | 267 | 0.160 |
Why?
|
Aged, 80 and over | 9 | 2019 | 58946 | 0.150 |
Why?
|
Aerosols | 1 | 2020 | 635 | 0.150 |
Why?
|
Bronchial Neoplasms | 1 | 2018 | 110 | 0.150 |
Why?
|
Peak Expiratory Flow Rate | 1 | 2017 | 143 | 0.150 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 3535 | 0.140 |
Why?
|
Intubation, Gastrointestinal | 1 | 2018 | 165 | 0.140 |
Why?
|
Fiducial Markers | 1 | 2018 | 132 | 0.140 |
Why?
|
Esophageal pH Monitoring | 1 | 2018 | 203 | 0.140 |
Why?
|
Prospective Studies | 7 | 2024 | 54419 | 0.140 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 251 | 0.140 |
Why?
|
Anesthesia | 2 | 2018 | 1591 | 0.140 |
Why?
|
Drug Administration Schedule | 3 | 2020 | 4849 | 0.130 |
Why?
|
Candidiasis | 1 | 2019 | 365 | 0.130 |
Why?
|
Cryptogenic Organizing Pneumonia | 1 | 2016 | 28 | 0.130 |
Why?
|
Pandemics | 3 | 2020 | 8663 | 0.130 |
Why?
|
Endoscopy, Digestive System | 1 | 2018 | 353 | 0.130 |
Why?
|
Gastrostomy | 1 | 2018 | 323 | 0.130 |
Why?
|
Postoperative Hemorrhage | 1 | 2019 | 416 | 0.130 |
Why?
|
Recurrence | 3 | 2020 | 8456 | 0.130 |
Why?
|
Talc | 1 | 2016 | 48 | 0.130 |
Why?
|
Adenocarcinoma | 1 | 2013 | 6340 | 0.130 |
Why?
|
Treatment Outcome | 11 | 2024 | 64670 | 0.120 |
Why?
|
Hemorrhage | 3 | 2022 | 3422 | 0.120 |
Why?
|
Escherichia coli Infections | 1 | 2019 | 518 | 0.120 |
Why?
|
Administration, Inhalation | 1 | 2018 | 1157 | 0.120 |
Why?
|
Anaplasmosis | 1 | 2015 | 37 | 0.120 |
Why?
|
Fluoroscopy | 1 | 2019 | 947 | 0.120 |
Why?
|
Streptococcal Infections | 1 | 2019 | 617 | 0.120 |
Why?
|
Bronchial Fistula | 1 | 2014 | 83 | 0.120 |
Why?
|
Thoracotomy | 1 | 2016 | 366 | 0.110 |
Why?
|
Time Factors | 5 | 2020 | 39953 | 0.110 |
Why?
|
Treatment Failure | 1 | 2020 | 2643 | 0.110 |
Why?
|
Anti-Bacterial Agents | 4 | 2019 | 7405 | 0.110 |
Why?
|
Communicable Diseases | 1 | 2022 | 873 | 0.110 |
Why?
|
Skin Neoplasms | 1 | 2013 | 5809 | 0.110 |
Why?
|
Quality Indicators, Health Care | 1 | 2023 | 1790 | 0.110 |
Why?
|
Adult | 14 | 2019 | 221083 | 0.110 |
Why?
|
Blister | 1 | 2013 | 86 | 0.110 |
Why?
|
Air | 1 | 2013 | 187 | 0.100 |
Why?
|
Enteral Nutrition | 1 | 2018 | 794 | 0.100 |
Why?
|
Antacids | 2 | 2022 | 94 | 0.100 |
Why?
|
Drug Combinations | 1 | 2018 | 2048 | 0.100 |
Why?
|
Breathing Exercises | 1 | 2012 | 59 | 0.100 |
Why?
|
Kidney Diseases | 2 | 2014 | 2092 | 0.090 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2016 | 2478 | 0.090 |
Why?
|
Bronchoalveolar Lavage | 1 | 2011 | 129 | 0.090 |
Why?
|
Tumor Lysis Syndrome | 1 | 2011 | 38 | 0.090 |
Why?
|
Vancomycin | 1 | 2014 | 503 | 0.090 |
Why?
|
Pilot Projects | 2 | 2021 | 8639 | 0.090 |
Why?
|
Surgery, Computer-Assisted | 1 | 2018 | 1004 | 0.090 |
Why?
|
Lymphoma | 1 | 2019 | 1898 | 0.090 |
Why?
|
Staphylococcal Infections | 1 | 2019 | 1400 | 0.090 |
Why?
|
Fiber Optic Technology | 1 | 2011 | 290 | 0.080 |
Why?
|
Lymphatic Metastasis | 2 | 2019 | 2913 | 0.080 |
Why?
|
Ultrasonography, Doppler | 1 | 2011 | 462 | 0.080 |
Why?
|
Radiosurgery | 1 | 2018 | 1339 | 0.080 |
Why?
|
Meditation | 1 | 2012 | 251 | 0.080 |
Why?
|
Radiography, Thoracic | 2 | 2013 | 1303 | 0.080 |
Why?
|
Positron-Emission Tomography | 3 | 2015 | 6585 | 0.080 |
Why?
|
Leiomyoma | 1 | 2013 | 636 | 0.080 |
Why?
|
Sensitivity and Specificity | 4 | 2020 | 14676 | 0.080 |
Why?
|
Yoga | 1 | 2012 | 281 | 0.080 |
Why?
|
Anesthesiology | 1 | 2018 | 1121 | 0.070 |
Why?
|
Hyponatremia | 1 | 2010 | 279 | 0.070 |
Why?
|
Patient Transfer | 1 | 2015 | 793 | 0.070 |
Why?
|
Cardiovascular Diseases | 1 | 2013 | 15513 | 0.070 |
Why?
|
Patient Selection | 2 | 2017 | 4245 | 0.070 |
Why?
|
Community-Acquired Infections | 1 | 2011 | 469 | 0.070 |
Why?
|
Disease Progression | 5 | 2023 | 13506 | 0.070 |
Why?
|
Survival Analysis | 1 | 2019 | 10083 | 0.070 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2011 | 423 | 0.070 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2010 | 369 | 0.070 |
Why?
|
Linear Models | 1 | 2016 | 5869 | 0.060 |
Why?
|
Bacterial Infections | 1 | 2013 | 1390 | 0.060 |
Why?
|
Clinical Laboratory Techniques | 1 | 2010 | 746 | 0.060 |
Why?
|
Exercise Therapy | 1 | 2012 | 922 | 0.060 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 5478 | 0.060 |
Why?
|
Uterine Neoplasms | 1 | 2013 | 1420 | 0.060 |
Why?
|
Drug Therapy, Combination | 3 | 2020 | 6305 | 0.060 |
Why?
|
Cisplatin | 1 | 2010 | 1651 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4060 | 0.060 |
Why?
|
Renal Insufficiency | 1 | 2010 | 808 | 0.060 |
Why?
|
Models, Animal | 2 | 2020 | 2114 | 0.060 |
Why?
|
Severity of Illness Index | 5 | 2019 | 15845 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2018 | 3163 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 3051 | 0.050 |
Why?
|
Enzyme Therapy | 1 | 2022 | 8 | 0.050 |
Why?
|
Students, Medical | 1 | 2015 | 1938 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 6975 | 0.050 |
Why?
|
Curriculum | 1 | 2015 | 3739 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2020 | 20120 | 0.050 |
Why?
|
Patient Discharge | 1 | 2015 | 3441 | 0.050 |
Why?
|
United States | 5 | 2022 | 72337 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2018 | 4251 | 0.050 |
Why?
|
Exhalation | 1 | 2022 | 182 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5318 | 0.040 |
Why?
|
Electrocoagulation | 1 | 2020 | 152 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39121 | 0.040 |
Why?
|
Residual Volume | 1 | 2019 | 40 | 0.040 |
Why?
|
Electromagnetic Phenomena | 1 | 2020 | 160 | 0.040 |
Why?
|
Pulmonary Atelectasis | 1 | 2020 | 143 | 0.040 |
Why?
|
Practice Guidelines as Topic | 2 | 2013 | 7400 | 0.040 |
Why?
|
Cardiology | 1 | 2010 | 1693 | 0.040 |
Why?
|
Bronchoscopes | 1 | 2018 | 64 | 0.040 |
Why?
|
Comorbidity | 3 | 2018 | 10514 | 0.040 |
Why?
|
Lasers, Solid-State | 1 | 2020 | 176 | 0.040 |
Why?
|
Age Factors | 2 | 2015 | 18385 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2012 | 11118 | 0.040 |
Why?
|
Oropharynx | 1 | 2018 | 137 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2018 | 4908 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2011 | 13630 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11475 | 0.040 |
Why?
|
Hemoptysis | 1 | 2018 | 151 | 0.030 |
Why?
|
Esophageal Stenosis | 1 | 2018 | 197 | 0.030 |
Why?
|
Benchmarking | 1 | 2023 | 1045 | 0.030 |
Why?
|
Pyridones | 1 | 2022 | 809 | 0.030 |
Why?
|
Contrast Media | 1 | 2010 | 5311 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2020 | 8519 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15308 | 0.030 |
Why?
|
Ventilators, Mechanical | 1 | 2018 | 288 | 0.030 |
Why?
|
Silicones | 1 | 2016 | 228 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2015 | 2025 | 0.030 |
Why?
|
Respiratory System | 1 | 2018 | 562 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2022 | 1264 | 0.030 |
Why?
|
Heart Failure | 2 | 2016 | 11701 | 0.030 |
Why?
|
Anaplasma phagocytophilum | 1 | 2015 | 37 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22125 | 0.030 |
Why?
|
Animals | 3 | 2021 | 168083 | 0.030 |
Why?
|
Blood Gas Analysis | 1 | 2015 | 379 | 0.030 |
Why?
|
Radiopharmaceuticals | 2 | 2015 | 2682 | 0.030 |
Why?
|
Indoles | 1 | 2022 | 1830 | 0.030 |
Why?
|
Fibrosis | 1 | 2020 | 2051 | 0.030 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2015 | 411 | 0.020 |
Why?
|
Device Removal | 1 | 2016 | 630 | 0.020 |
Why?
|
Young Adult | 1 | 2017 | 59199 | 0.020 |
Why?
|
Inappropriate ADH Syndrome | 1 | 2010 | 61 | 0.020 |
Why?
|
Exercise Tolerance | 1 | 2015 | 838 | 0.020 |
Why?
|
Swine | 1 | 2020 | 5909 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2014 | 1837 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2015 | 1187 | 0.020 |
Why?
|
Steroids | 1 | 2015 | 929 | 0.020 |
Why?
|
Hemoglobins | 1 | 2015 | 1525 | 0.020 |
Why?
|
Adolescent | 1 | 2017 | 88271 | 0.020 |
Why?
|
Home Care Services | 1 | 2015 | 647 | 0.020 |
Why?
|
Creatinine | 1 | 2014 | 1897 | 0.020 |
Why?
|
Kidney Function Tests | 1 | 2010 | 680 | 0.020 |
Why?
|
Hospitals, Community | 1 | 2010 | 365 | 0.020 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3196 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2010 | 1155 | 0.020 |
Why?
|
Syndrome | 1 | 2010 | 3269 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2010 | 2424 | 0.010 |
Why?
|
Glomerular Filtration Rate | 1 | 2010 | 2181 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7804 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15717 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7969 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13254 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2013 | 2478 | 0.010 |
Why?
|
Esophageal Neoplasms | 1 | 2010 | 1658 | 0.010 |
Why?
|
Smoking | 1 | 2015 | 9055 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2010 | 4506 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2019 | 15634 | 0.010 |
Why?
|
Incidence | 1 | 2014 | 21357 | 0.010 |
Why?
|
Risk Factors | 2 | 2014 | 74219 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2010 | 4021 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 26068 | 0.010 |
Why?
|
Hypertension | 1 | 2013 | 8537 | 0.010 |
Why?
|
Cohort Studies | 1 | 2016 | 41486 | 0.010 |
Why?
|
Prognosis | 1 | 2010 | 29672 | 0.010 |
Why?
|